APEX Healthcare stable strong growth performance

We have been holding APEX Healthcare 4 years ago and we continue to call for a hold. Buy if market in weak position. Pharmacy and drugs related business has given APEX a stable growth trend. Strong revenue increased with mild profit increment may drive the company EPS ratio around 10 and below. Given pharmaceutical industry valuation above 15 times. APEX worth around RM 6.00 and above. With a propose bonus issue up coming. We believe the stock will be a long term hold for us.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Create a free website or blog at WordPress.com.

Up ↑

%d bloggers like this: